Inter-rater reliability and agreement of the General Movement Assessment and Motor Optimality Score-Revised in a large population-based sample.

Early Hum Dev

Child and Adolescent Health Service, 15 Hospital Avenue, Nedlands, Western Australia 6009, Australia; Telethon Kids Institute, 15 Hospital Avenue, Nedlands, Western Australia, 6009, Australia.

Published: June 2024

AI Article Synopsis

  • Prechtl's General Movement Assessment (GMA) is a key tool for detecting cerebral palsy in infants aged 3-5 months, and this study evaluates its reliability alongside the Motor Optimality Score-Revised (MOS-R).
  • A cross-sectional study involving 773 infants was conducted in Perth using home-recorded videos, which were evaluated by two experienced assessors to measure inter-rater reliability.
  • Results indicated that GMA classification demonstrated nearly perfect reliability and agreement, while MOS-R showed good to excellent reliability, confirming the assessment's consistency for population-based studies.

Article Abstract

Background: Prechtl's General Movement Assessment (GMA) at fidgety age (3-5 months) is a widely used tool for early detection of cerebral palsy. Further to GMA classification, detailed assessment of movement patterns at fidgety age is conducted with the Motor Optimality Score-Revised (MOS-R). Inter-rater reliability and agreement are properties that inform test application and interpretation in clinical and research settings. This study aims to establish the inter-rater reliability and agreement of the GMA classification and MOS-R in a large population-based sample.

Methods: A cross-sectional study of 773 infants from birth-cohort in Perth, Western Australia. GMA was conducted on home-recorded videos collected between 12 + 0 and 16 + 6 weeks post term age. Videos were independently scored by two masked experienced assessors. Inter-rater reliability and agreement were assessed using intraclass correlation coefficient and limits of agreement respectively for continuous variables, and Cohen's Kappa and Gwet's Agreement Coefficient, and percentage agreement respectively for discrete variables.

Results: The classification of GMA showed almost perfect reliability (AC = 0.999) and agreement (99.9 %). Total MOS-R scores showed good-excellent reliability (ICC 0.857, 95 % CI 0.838-0.876) and clinically acceptable agreement (95 % limits of agreement of ±2.5 points). Substantial to almost perfect reliability and agreement were found for all MOS-R domain subscores. While MOS-R domains with higher redundancy in their categorisation have higher reliability and agreement, inter-rater reliability and agreement are substantial to almost perfect at the item level and are consistent across domains.

Conclusion: GMA at fidgety age shows clinically acceptable inter-rater reliability and agreement for GMA classification and MOS-R for population-based cohorts assessed by experienced assessors.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.earlhumdev.2024.106019DOI Listing

Publication Analysis

Top Keywords

reliability agreement
32
inter-rater reliability
24
agreement
14
fidgety age
12
gma classification
12
reliability
9
general movement
8
movement assessment
8
motor optimality
8
optimality score-revised
8

Similar Publications

Background: Peak-width of skeletonized mean diffusivity (PSMD) is an emerging biomarker of cerebral small vessel disease (cSVD)-related vascular contributions to cognitive impairment and dementia (VCID). Higher PSMD values reflect greater white matter microstructural damage, and prior research has related PSMD to sporadic and monogenic forms of cSVD and worse cognitive function. Therefore, we proposed PSMD as a risk stratification biomarker for VCID.

View Article and Find Full Text PDF

Background And Purpose:  Computed tomography radiostereometric analysis (CT-RSA) assesses implant micromovements using low-dose CT scans. We aimed to investigate whether CT-RSA is comparable to marker-based radiostereometric analysis (RSA) measuring early femoral head migration in cemented stems. We hypothesized that CT-RSA is comparable to marker-based RSA in evaluating femoral head subsidence.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Background: In this pilot study, the diagnostic agreement for sleep biomarker-based neurodegenerative disorder (NDD) risk probabilities was evaluated in patients with Alzheimer's disease dementia (AD), Lewy body disease (LBD), mild cognitive impairment (MCI), and controls (CG) with a Mini-Mental State Exam scores ≥28.

Methods: Sleep biomarkers recorded with the Sleep Profiler (Advanced Brain Monitoring, Inc.) were used as inputs to a 4-class machine learning algorithm trained to assign NDD risk probabilities to AD=27, LBD=19, isolated REM sleep behavior disorder=15, and CG=58.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

CSIRO Health and Biosecurity, Australian E-Health Research Centre, Parkville, VIC, Australia.

Background: PET quantification using the Standardised Uptake Value Ratio (SUVR) relies on the availability of a robust reference region. Intrinsic noise, spill in, and specific binding in the reference region can impact the reliability of the resulting SUVR. We evaluate a novel deep learning method trained on longitudinal data that penalises unexpected temporal changes and learns a SUVR correction factor that compensates for any noise or bias in the reference region, resulting in an improved quantification.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Division of Nuclear Medicine, Geneva University Hospitals, Geneva, Switzerland.

Background: Substantial variability in tau accumulation patterns in Alzheimer's disease (AD) population has now become accepted. Subtype and Stage Inference (SuStaIn) has distinguished four distinct spatiotemporal trajectories of tau pathology: limbic (S1), medial temporal lobe-sparing (S2), posterior (S3), and lateral temporal (S4). A visual method to validate and identify them is a requirement for their clinical translation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!